Physician profile
Soroosh Behshad
NPI 1578850806
$7,371.76
in general payments reported to CMS, 2019-2025
10 companies · $439 in 2025
The $439 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.56 · 2022: $218 · 2023: $1,211 · 2024: $5,454 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,850 · Food and Beverage: $1,240 · Travel and Lodging: $14.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,850.00 |
| Food and Beverage | $1,239.51 |
| Travel and Lodging | $14.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $5,958.76 | 2023-2025 | Kxl System (Not Refurbished), Ce-Marked Kxla System, Istent Infinite |
| Johnson & Johnson Surgical Vision, INC. | $362.40 | 2019-2024 | Tecnis Iol, Tecnis Simplicity |
| Harrow Eye, LLC | $219.29 | 2024-2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $167.73 | 2024 | Quatera 700, Iolmaster 700 |
| Dompe US, INC. | $150.03 | 2023-2025 | Oxervate |
| New World Medical,INC. | $150.00 | 2024 | Streamline, Kahook Dual Blade, Clearpath |
| Biotissue Holdings INC. | $134.42 | 2025 | |
| Alcon Vision LLC | $93.12 | 2023-2025 | Centurion, Unity |
| Rxsight INC | $76.78 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $59.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soroosh Behshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.